Agilent Technologies (A)

• Market cap: $33.2B
• 1 day: -1.54%
• 5 days: 0.40%
• 1 month: 1.44%
• 3 months: -0.21%
• 6 months: -15.77%
• Year to date: -12.25%
• 1 year: -10.33%
• 5 years: 34.64%
• 10 years: 196.26%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Employees: 17,900

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

18% more call options, than puts

Call options by funds: $138M | Put options by funds: $116M

13% more funds holding in top 10

Funds holding in top 10: 8 [Q4 2024] → 9 (+1) [Q1 2025]

1.23% less ownership

Funds ownership: 88.29% [Q4 2024] → 87.06% (-1.23%) [Q1 2025]

6% less funds holding

Funds holding: 1,060 [Q4 2024] → 997 (-63) [Q1 2025]

14% less capital invested

Capital invested by funds: $33.9B [Q4 2024] → $29B (-$4.87B) [Q1 2025]

17% less repeat investments, than reductions

Existing positions increased: 328 | Existing positions reduced: 397

30% less first-time investments, than exits

New positions opened: 96 | Existing positions closed: 138

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $115 2% downside
• Avg. target: $131 11% upside
• High target: $155 32% upside

8 analyst ratings

• positive: 3 38%
• neutral: 5 63%
• negative: 0 0%

UBS Elizabeth Garcia	11% upside $130	Neutral Maintained	29 May 2025
JP Morgan Tycho Peterson	32% upside $155	Overweight Maintained	29 May 2025
Baird Catherine Schulte	20% upside $140	Outperform Maintained	22 May 2025
Jefferies Brandon Couillard	1% downside $116	Hold Maintained	21 Apr 2025
Wells Fargo Brandon Couillard	15% upside $135	Overweight Maintained	17 Apr 2025